Ketamine for Chronic Pain: How It Works and What to Know

What Is Ketamine and Why Is It Used for Chronic Pain?

Ketamine is a medication that temporarily modulates neural communication to provide relief for severe, treatment-resistant chronic pain. It was first FDA-approved as an anesthetic in 1970.¹

The medication has also been on the World Health Organization's List of Essential Medicines since 1985.² While its original approval was for anesthesia, clinicians frequently prescribe ketamine off-label for chronic pain management.

Off-label prescribing is a standard, legally recognized medical practice.¹⁰ In fact, off-label use accounts for approximately 21% of all prescriptions in the United States.³

Clinicians turn to this treatment when conventional analgesics provide incomplete relief. Medications like nonsteroidal anti-inflammatory drugs (NSAIDs) or opioids often carry significant long-term risks.

Ketamine acts on a fundamentally different neural pathway. This makes it a valuable option when other mechanisms have been exhausted.

Clinicians consider it for pain management for several key reasons:

• Different mechanism of action: It targets the NMDA receptor system rather than opioid or inflammatory pathways.
• Opioid-sparing potential: It may help reduce the need for long-term opioid medications.
• Dual action: It simultaneously addresses pain and overlapping mood symptoms like depression.

Chronic pain and depression frequently co-occur — an estimated 50–60% of people with chronic pain also experience clinically significant depression, and each condition amplifies the other. Ketamine simultaneously addresses pain signaling and overlapping mood symptoms, which is why the comorbidity angle matters clinically, not just as a secondary benefit.

How Does Ketamine Work for Chronic Pain?

Ketamine primarily works by modulating N-methyl-D-aspartate (NMDA) receptors in the brain and spinal cord.⁴ These receptors play a central role in how your nervous system processes, amplifies, and remembers pain signals.

In chronic pain states, these receptors can become hyperactive. This leads to a phenomenon called central sensitization.

Central sensitization causes the nervous system to amplify pain input beyond what the original injury warrants. Ketamine addresses this through three interconnected pathways:

• NMDA receptor modulation: Ketamine temporarily adjusts signaling at these receptors to interrupt the wind-up phenomenon. This helps recalibrate how your nervous system interprets incoming sensory information.
• Neuroplasticity promotion: The medication promotes synaptic plasticity, helping the brain form new neural connections and offering the nervous system a chance to reorganize and bypass entrenched pain circuits. Emerging research suggests this window of heightened plasticity may also make it easier to build and sustain complementary habits — such as mindfulness-based stress reduction (MBSR), which has its own evidence base for chronic pain management.
• Descending inhibitory pathways: Ketamine enhances the body's natural pain-modulating systems while affecting mood-related neurotransmitters like glutamate. Because depression and chronic pain share overlapping neural circuits, addressing both simultaneously can produce compounding benefits.

What Types of Chronic Pain Does Ketamine Treat?

Ketamine is most extensively studied and utilized for neuropathic pain. This is pain caused by nerve damage or nervous system dysfunction.

It is particularly relevant for conditions with a strong central sensitization component. Evidence strength varies by condition, with the most robust data supporting its use in complex nerve-related disorders.⁵

A clinician's assessment of your specific pain type and mechanism is essential. This evaluation determines if this treatment is appropriate for your unique biology.

The conditions with the strongest evidence base include:

• Complex Regional Pain Syndrome (CRPS): This is one of the most-studied indications, with multiple trials supporting ketamine's role in reducing severe CRPS pain intensity.
• Fibromyalgia: Clinical evidence suggests benefit particularly for the central sensitization and widespread allodynia associated with fibromyalgia.¹¹
• Phantom limb pain: By modulating NMDA receptors, the medication may help interrupt the cortical reorganization that drives phantom sensations after amputation.¹²
• Diabetic neuropathy: This represents a broad category of nerve injuries where NMDA-mediated mechanisms are well-established contributors to pain.

How Is Ketamine Administered for Pain Relief?

Ketamine for chronic pain can be delivered through several routes. Each method offers different bioavailability, onset times, and clinical setting requirements.¹³

Bioavailability refers to the percentage of the medication that actually reaches your bloodstream. No single route is universally superior for every patient.

Route selection depends on your clinical scenario, pain severity, and personal preference. Each method involves trade-offs between convenience, monitoring requirements, and cost. Some clinician-supervised at-home programs, including Mindbloom, offer sublingual and subcutaneous administration within a structured screening, monitoring, and follow-up protocol.

How Long Does Ketamine Pain Relief Last?

The duration of pain relief from ketamine varies substantially based on the route of administration. It also depends on the underlying condition and individual biological factors.

There is no single universal timeline for how long the benefits will endure. A single session may provide temporary relief, but a defined treatment framework often produces more durable changes.

Repeated NMDA modulation allows for more sustained neuroplastic remodeling over time. The expected duration typically aligns with the treatment approach:

• Short IV infusions: Relief from a 40-to-60-minute session may last from a few days to several weeks.¹⁴ Some patients report benefit only during the administration window.
• Prolonged IV infusions: Multi-day inpatient protocols can produce relief lasting weeks to months.¹⁵ These are typically reserved for severe, refractory cases like CRPS.
• Sublingual and subcutaneous routes: These generally have a shorter duration of effect per individual session. They are often used as part of a recurring treatment series to build cumulative benefit.
• Repeated treatment series: Many patients require periodic retreatment to maintain their progress. The interval between series varies widely based on clinician-guided scheduling.

What Side Effects Can Ketamine Cause During Pain Treatment?

Like all medications, ketamine carries potential side effects. At the sub-anesthetic, clinician-determined doses used for pain management, most side effects are temporary.

Common acute effects such as nausea, dizziness, drowsiness, and perceptual changes often lessen as the medication wears off over several hours, though timing varies by route, dose, and individual response. Understanding ketamine's short and long-term side effects helps you prepare for the experience.

Serious adverse events in supervised, protocol-driven ketamine treatment are rare. Common side effects include nausea, dizziness, drowsiness, and changes in visual or auditory perception.

• Dissociation: You may experience a feeling of dissociation, which is a sense of detachment from the body or surroundings. Most people find this dissociative state manageable or even meaningful within a clinical setting. If the experience feels unfamiliar, preparation materials and your support person can help you navigate it.
• Cardiovascular effects: Some people experience a temporary increase in blood pressure and heart rate during the session. This occurs because ketamine has sympathomimetic properties, meaning it temporarily stimulates the cardiovascular system. Individuals with uncontrolled hypertension may not be appropriate candidates, which is why cardiovascular screening is part of the intake process.
• Long-term considerations: Long-term, high-dose recreational ketamine use has been associated with bladder complications like interstitial cystitis.⁶ This condition causes severe pelvic pain due to organ toxicity from chronic, unmonitored abuse. In clinical settings, proactive safeguards and defined treatment durations mitigate these risks.

Who Should Not Receive Ketamine for Pain?

Ketamine therapy may not be appropriate for everyone. Eligibility is determined through a comprehensive clinical assessment process.

Clinicians evaluate your medical history to identify potential contraindications. These considerations are not always absolute barriers, but rather factors a qualified clinician weighs during screening.

The goal is to identify patients for whom the medication can be both safe and effective. Key clinical considerations include:

• Uncontrolled hypertension: Because the medication can temporarily increase blood pressure, individuals with unstable cardiac conditions require careful evaluation. Cardiovascular screening ensures your heart can handle the temporary stimulation.
• History of psychosis: Ketamine's psychomimetic properties can alter perception and thought patterns. This may not be appropriate for individuals with schizophrenia or active psychotic disorders, which is why psychiatric screening is required.
• Active substance use disorder: As a Schedule III substance, ketamine carries some potential for psychological dependence. This risk is primarily documented in chronic, unsupervised recreational use patterns.⁶ In a clinically managed program, comprehensive screening and clinician oversight serve as proactive safeguards against misuse.
• Medication interactions: Central nervous system (CNS) depressants like benzodiazepines, opioids, and alcohol can compound sedation. Your clinician will carefully evaluate your current prescriptions to prevent dangerous interactions.

How Does Ketamine Compare to Other Chronic Pain Treatments?

Chronic pain management typically involves a multimodal approach. This means multiple therapies are used together to address different aspects of the pain.

Ketamine occupies a specific niche as an additional tool with a distinct mechanism. It is not a replacement for all other treatments.

Its unique action on the NMDA receptor makes it complementary to most other pain interventions. Understanding how these options differ can help guide your care plan.

• Opioids: These medications bind to mu-opioid receptors and are effective for acute or severe pain. However, they carry well-documented risks of tolerance and hyperalgesia with long-term use. Ketamine offers opioid-sparing potential, meaning it may allow patients to reduce their opioid requirements.
• Gabapentin and Pregabalin: These anticonvulsants target calcium channels to calm overactive nerves. While they are first-line treatments for neuropathic pain, some patients experience incomplete relief. Ketamine acts on a fundamentally different neural pathway, offering an alternative when anticonvulsants fall short.
• Nerve Blocks: These interventional procedures interrupt peripheral nerve signals to stop localized pain. They are highly effective for specific anatomical pain generators. Ketamine addresses central, brain-level sensitization, which can complement these peripheral interventions.

What Does the Research Say About Ketamine for Chronic Pain?

Ketamine's use in chronic pain is supported by multiple randomized controlled trials and systematic reviews. While the evidence base is stronger for some conditions than others, decades of clinical use support its place in the pain management toolkit.

Research is actively expanding to establish standardized dosing protocols across different pain subtypes. The evidence landscape highlights several key areas where ketamine demonstrates clinical utility.

Direct comparisons across treatment modalities should be interpreted with caution due to differences in study design, patient populations, and outcome measures.

• Complex Regional Pain Syndrome: CRPS is among the most-studied indications. Systematic reviews demonstrate significant pain reduction following intravenous protocols.⁵
• Neuropathic pain: Meta-analyses evaluating the medication across various neuropathic pain subtypes show generally favorable findings, highlighting short-to-medium-term pain reduction.¹⁶
• Opioid-sparing effects: Several studies demonstrate that the treatment can reduce postoperative and chronic opioid requirements.⁷ This offers a crucial benefit for patients on long-term opioid therapy.
• Mood and pain co-occurrence: Research increasingly recognizes the overlap between chronic pain and depression circuits. Ketamine's dual action on both may explain why some patients experience holistic improvements beyond pain scores alone.

How Clinician-Supervised Protocols Support Safe Ketamine Pain Treatment

What distinguishes responsible ketamine therapy from unsupervised use is the clinical framework surrounding the medication. Safety and outcomes are determined by comprehensive screening, monitoring, and integration.

A protocol-driven approach ensures that risks are proactively managed. It also ensures that doses are personalized to your specific clinical factors.

A clinically managed program includes several essential safety components:

• Comprehensive screening: Intake involves a medical history review, cardiovascular assessment, and medication interaction check. This identifies contraindications before treatment begins.
• Clinician-determined dosing: Doses are personalized based on weight, pain condition, and response history. Safety is a function of clinical supervision, not dose size alone.⁸
• Monitored sessions: Whether in-clinic or at-home, safe administration requires monitoring. In Mindbloom's program, a peer treatment monitor must be present for every session.
• Integration and follow-up: Post-session clinical check-ins allow providers to assess your response. This ongoing feedback loop enables personalized, adaptive care.

Mindbloom has facilitated over 700,000 clinician-supervised at-home ketamine sessions. Building on decades of clinical research, Mindbloom published two of the largest peer-reviewed, real-world outcomes studies of at-home ketamine therapy to date in the Journal of Affective Disorders.^8,9

Conducted on Mindbloom clients using the Mindbloom protocol, these studies demonstrated a safety profile with side effects occurring at approximately 4-5%. Serious adverse events occurred at less than 0.1% of sessions (results may vary).

It is important to note that Mindbloom does not diagnose or treat chronic pain as a standalone condition. Mindbloom's programs are designed to treat clinician-diagnosed mental health conditions like anxiety, depression, and PTSD. However, because chronic pain and mental health conditions so frequently co-occur, clients who qualify based on a mental health diagnosis may also experience improvements in how they relate to pain.

What to Discuss with Your Clinician Before Starting Ketamine for Pain

Ketamine is a clinically established option for chronic pain with a distinct mechanism. It has a well-documented safety profile when administered under clinician-supervised protocols.

It offers a unique approach, particularly for neuropathic pain conditions that have not responded to conventional treatments. Before beginning treatment, have an informed conversation with a pain management clinician.

Discuss whether this medication fits within your overall care plan. Because individual responses vary, it is most effective when integrated into a comprehensive, multimodal approach to your health.

Disclaimer

IMPORTANT SAFETY INFORMATIONKetamine is not FDA-approved for PTSD, depression, or anxiety. Common side effects include dissociation, increased blood pressure, nausea, dizziness, and cognitive impairment. Ketamine has abuse potential and is not appropriate for patients with uncontrolled hypertension, psychotic disorders, or substance use disorders. Do not drive or operate machinery until the day after treatment. Individual results may vary. Full safety information: www.mindbloom.com/safety-information

‍OFF-LABEL USE DISCLOSUREKetamine is FDA-approved only as an anesthetic. Use for mental health conditions represents off-label prescribing by licensed clinicians based on clinical judgment. Schedule III Controlled Substance - DEA regulations apply.